Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HUMA
#3066
Humacyte, Inc. Common Stock
1.1
2
-6.67%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-6.67%
Monatliche Änderung
+7.69%
6 month change
-28.66%
Jahresänderung
-66.06%
Vorheriger Schlusskurs
1.2
0
Open
1.1
2
Bid
Ask
Low
1.1
2
High
1.1
2
Volumen
61
Märkte
Aktien
Gesundheitswesen
HUMA
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
125.86 M
155.12 M
155.12 M
158.37 M
187.27 M
—
Valuation ratios
Enterprise value
664.1 M
738.41 M
201.63 M
292.97 M
306.36 M
1.54 B
Price to earnings ratio
-4.06
-4.01
-2.47
-4.64
-7.57
-18.69
Price to sales ratio
—
—
434.53
356.64
163.89
—
Price to cash flow ratio
6.75
6.1
2.1
2.6
2.28
13.08
Price to book ratio
4.76
11.36
1.14
1.64
2.25
16.39
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.34
0.15
0.24
0.27
0.19
0.86
Return on equity %
0.62
0.4
1.09
9.29
3.69
14.46
Return on invested capital %
173.23
119
98.9
127.9
131.63
477.43
Gross margin %
—
—
71.57
29.24
65.47
—
Operating margin %
—
—
4 487.43
9 876.08
3 239.04
—
EBITDA margin %
—
—
-4 232.88
-9 676.74
-3 066.4
—
Net margin %
—
—
7 570.41
12.51 K
2 325.37
—
Liquidity ratios
Quick ratio
—
—
3.28
1.93
0.9
—
Current ratio
1.1
2.4
3.68
2.45
1.62
10.15
Inventory turnover
—
—
0.02
0.02
0.02
—
Asset turnover
0
—
0
0
0.01
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.54
0.46
0.4
0.48
0.19
1.53
Long term debt to total equity ratio
0.97
1.2
1.79
16.39
3.72
23.11
Per share metrics
Operating cash flow per share
0.19
0.22
0.22
0.17
0.15
0.76
EBIT per share
—
—
-0.18
-0.2
-0.16
—
EBITDA per share
—
—
-0.17
-0.19
-0.15
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.17
0.38
0.48
0.24
0.12
1.22
Net current asset value per share
0.19
0.4
0.56
0.33
0.26
1.56
Tangible book value per share
0.53
0.44
0.27
0.03
0.03
0.77
Working capital per share
0.02
0.24
0.41
0.2
0.1
0.94
Book value per share
0.53
0.44
0.27
0.03
0.03
0.77
Nachrichten
Humacyte, Inc. (HUMA) Falls More Steeply Than Broader Market: What Investors Need to Know
BTIG reiterates Buy rating on Humacyte stock amid DoD funding news
Humacyte stock jumps after securing DoD funding for vascular repair tech
DoD allocates funds for bioengineered vascular repair tech in 2026 budget
Humacyte, Inc. (HUMA) Exceeds Market Returns: Some Facts to Consider
Benchmark lowers Humacyte stock price target to $10 on Israel filing plans
Is Humacyte, Inc. (HUMA) Outperforming Other Medical Stocks This Year?
Humacyte plans to seek approval for vessel product in Israel
Humacyte secures up to $77.5 million credit facility with Avenue Capital
Wall Street Analysts See Humacyte, Inc. (HUMA) as a Buy: Should You Invest?
Humacyte stock rating reiterated at Buy by H.C. Wainwright
Should You Invest in Humacyte, Inc. (HUMA) Based on Bullish Wall Street Views?